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oThe importance of behavioral counseling as a clinical preventive service derives from the social and
economic burden of preventable disease in the U.S., the central role behavioral risk factors play as
leading causes of premature morbidity and mortality, and the promise of the healthcare visit as a
teachable moment for behavioral counseling support. In November 2013, the U.S. Preventive
Services Task Force convened an expert forum on behavioral counseling interventions. The forum
brought together NIH, CDC, and Agency for Healthcare Research and Quality leaders, leading
behavioral counseling researchers, and members of the U.S. Preventive Services Task Force to
discuss issues related to optimizing evidence-based behavioral counseling recommendations. This
paper provides an overview of the methods used by the Task Force to develop counseling
recommendations. Special focus is on the development and evaluation of evidence from systematic
reviews. Assessment of the net beneﬁt of a behavioral counseling intervention, based on the evidence
review, determines the recommendation statement and accompanying letter grade. A recent Task
Force recommendation on screening and behavioral counseling interventions in primary care to
reduce alcohol misuse provides a brief example.
(Am J Prev Med 2015;49(3S2):S129–S137) & 2015 American Journal of Preventive Medicine. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionIn November 2013, the U.S. Preventive Services TaskForce (USPSTF) convened an expert forum onbehavioral counseling interventions. The forum
provided a unique opportunity to bring together NIH,
CDC, and Agency for Healthcare Research and Quality
(AHRQ) leaders, leading behavioral counseling research-
ers, and members of the USPSTF to discuss issues related
to optimizing evidence-based behavioral counseling rec-
ommendations. The meeting focused on optimizing Task
Force methods for developing counseling recommenda-
tions, optimizing behavioral counseling research that
forms the basis for evidence-based recommendations,
and expanding opportunities for funded research that
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pen access article under the CC BY-NC-ND license (httpevidence reviews conducted as part of the recommenda-
tion process. The agenda and roster of participants is
included in the Appendix (available online).Why Behavioral Counseling?
Underlying the importance of behavioral counseling as a
clinical preventive service are four foundational prem-
ises. First, the level of spending on health and health care
in the U.S. does not lead to better population health
status.1 For example, among 34 members of the Organ-
ization for Economic Cooperation and Development, the
U.S. ranks below average across multiple health status
measures, including infant mortality (31/34); life expect-
ancy from birth (26/34); and obesity among children (30/
34) and among adults (34/34).1 Second, behavioral risk
factors contribute substantially to the leading causes of
premature morbidity and mortality, including heart
disease, cancer, chronic lower respiratory disease, and
diabetes.2 So great is their contribution that tobacco use,
poor diet and physical activity, and alcohol consumption
have been identiﬁed as the top three actual causes of
death.3 Behavioral patterns are estimated to contribute
40% to premature death, greater than genetic dispositionvier Inc.
://creativecommons.org/licenses/by-nc-nd/4.0/).
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exposures (5%); and health care (10%) combined.2
The economic impact of behavioral risk factors is the
third premise. In 2011, U.S. expenditures on health care
were $2.7 trillion.4 Of every dollar spent on health care,
$0.75 goes for treatment of preventable diseases (this cost
rises in Medicare to $0.96 and in Medicaid to $0.83).5
Thus, addressing behavioral risk factors has tremendous
potential and brings us to the fourth premise: the
healthcare setting has great promise as a channel for
counseling to address behavioral risk factors. The over-
whelming majority of individuals in the U.S. have at least
one visit with a primary care provider annually.6 Primary
care providers are respected, credible professionals who
can motivate and encourage behavior change. The
healthcare visit often provides a “teachable moment”
for personalizing messages and support for behavioral
counseling.7 Health information technology or electronic
medical records can facilitate identiﬁcation of individuals
appropriate for counseling interventions and referral, as
well as continuity and follow-up opportunities in sub-
sequent visits.8 Realizing this promise requires a science
base for effective behavioral counseling interventions,
which was the focus of the USPSTF forum.U.S. Preventive Services Task Force
Methods
The USPSTF is an independent panel of nonfederal
experts in prevention and evidence-based medicine that
makes recommendations on clinical preventive services
to primary care clinicians. The scope for clinical pre-
ventive services includes screening tests, counseling, and
preventive medications. Services are offered in or
referred from a primary care setting. As preventive
services, the recommendations apply to individuals
(adults and children) with no signs or symptoms of that
disease. The USPSTF was an early adopter in basing its
recommendations on rigorous systematic reviews of
existing peer-reviewed evidence, now considered a stand-
ard for trustworthy recommendations.9 The Task Force
does not conduct research studies; it reviews and assesses
existing research. Both the beneﬁts and harm of each
preventive service are evaluated. As background to the
issues discussed at the forum, we provide a brief overview
of the Task Force’s general methods for developing
recommendations including the methods used to con-
duct the evidence reviews that form the foundation of
Task Force recommendations. This overview is not
intended to be a comprehensive summary; more detailed
information can be found at www.uspreventiveservices
taskforce.org.General Procedures for Developing a
Recommendation Statement
Figure 1 summarizes the sequence of procedures for
developing a recommendation statement. Several fea-
tures of these procedures merit emphasis. First, there are
multiple opportunities for public input to the work of the
Task Force with regard to nomination of topics, review of
the systematic review work plan, and review of the draft
recommendation. Second, the development of a recom-
mendation from work plan development through evi-
dence review to drafting and ﬁnalizing a recommendation
takes approximately 18–24 months. The Task Force works
with partner organizations and experts to obtain input and
peer review of key products, including work plans,
evidence reports, and draft recommendations.
Topic nominations can suggest a new preventive
service topic or recommend reconsideration of an exist-
ing topic owing to the availability of new evidence,
changes in the public health burden on the condition,
or the availability of new interventions supported by new
evidence. Nominations are accepted year round and are
considered by the USPSTF at its three annual meetings.
The four main considerations in prioritizing and select-
ing topics are as follows:1. whether the topic is within the scope of the Task Force
(e.g., does it focus on prevention versus diagnosis and
treatment and is it relevant to the primary care setting?);2. the public health importance of the condition to be
prevented, including the burden of suffering and the
expected effectiveness of the preventive service;3. the potential of the Task Force recommendation to
have an impact on clinical practice (e.g., is there an
existing controversy or is there believed to be a gap
between evidence and practice?); and4. the intensity of resources needed (e.g., How broad
does the evidence review need to be?).
Developing the Systematic Review
For each new or updated topic, a subset of three to four
Task Force members (leads) and a medical ofﬁcer from
AHRQ work with an Evidence-Based Practice Center
(EPC) to develop a work plan for the systematic evidence
review to be conducted by the EPC. The work plan uses
established USPSTF approaches11 to deﬁne the topic scope
and outline the series of discrete clinical actions from
patient identiﬁcation through to health outcomes as
required to achieve the net impact of the preventive service;
these specify the key issues for systematic review evaluation
as well. The work plan outlines the review approach to
searching and selection of the evidence and any contextual
issues to be addressed. After public comment and revision,www.ajpmonline.org
Figure 1. Steps the USPSTF takes to make a recommendation.10
Source: U.S. Preventive Services Task Force. Steps the USPSTF Takes to Make a Recommendation. 2014. www.uspreventiveservicestaskforce.org/
Page/Name/steps-the-uspstf-takes-to-make-a-recommendation.
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posting and to guide the EPC in conducting the review.
Once the topic is scoped, the systematic review adheres to
the ﬁnal work plan through a multistep methodologic
process with six additional phases (Table 1). Scientiﬁc
databases and other sources are searched to locate all
potentially relevant studies; these are screened for relevance
and qualiﬁed through critical appraisal to be reasonably free
of study-level bias, with key data from included articles
abstracted into standardized evidence tables. Outcomes are
summarized across studies qualitatively, as well as quantita-
tively when appropriate, to support decision making by the
USPSTF. In the ﬁnal phase, systematic review results are
shared with the USPSTF, peer reviewers, and others for
consideration and input prior to revision and publication of
ﬁnal ﬁndings in the public domain. Even as the systematicSeptember 2015review itself is completed, the EPC continues to support the
USPSTF as it evaluates the body of evidence. This “evidence
chaperone” role represents an active handoff of the evidence
synthesis to the decision makers to maintain the integrity of
the review throughout its application in developing a
recommendation statement by the USPSTF. In other words,
the EPC participates in calls and reviewing documents to
ensure that there is clear understanding of the reviewed
evidence and consistency in the communication of the
evidence basis for the recommendation statement with the
systematic review.
Task Force Evaluation of Evidence From the
Systematic Review
The evidence review provides the foundation on which
the Task Force leads assess the net beneﬁt of a preventive
Table 1. Phases of Systematic Review
Phase Description
Scope Formulate topic and develop work plan
Search Locate all potentially relevant studies
Screen Include studies and abstract data
Qualify Critically appraise included studies
Summarize Synthesis for decision making
Share External review, revision, report
Support Ensure understanding of systematic review
ﬁndings, integrity of its use
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the balance of the potential health beneﬁts and harm of a
preventive service. As shown in Table 2, recommenda-
tions can have letter grades of A, B, C, D, or I.
There are six main considerations in evaluating the
available evidence from the systematic review. The ﬁrst
three relate to the quality of the research studies in the
evidence review. The Task Force focuses on whether the
studies have the appropriate research design; the quality
of the study components (internal validity); and the
applicability of the studies to the general U.S. primary
care population and treatment models (external validity).
The other three considerations focus on the number and
size of studies that have been conducted that address the
key questions in the analytic framework (precision of the
evidence); consistency in the study ﬁndings; and other
factors that may support or undermine potential con-
clusions, such as the presence or absence of a dose–
response effect or ﬁt with a biological model. Together,Table 2. U.S. Preventive Services Task Force Recommendation
Grade Deﬁnition
A The USPSTF recommends the service. There is high cert
substantial.
B The USPSTF recommends the service. There is high cert
moderate or there is moderate certainty that the net b
substantial.
C The USPSTF recommends selectively offering or providin
patients based on professional judgment and patient p
least moderate certainty that the net beneﬁt is small.
D The USPSTF recommends against the service. There is
that the service has no net beneﬁt or that the harms o
I
Statement
The USPSTF concludes that the current evidence is ins
balance of beneﬁts and harms of the service. Evidence
or conﬂicting, and the balance of beneﬁts and harms c
Source: U.S. Preventive Services Task Force. Grade Deﬁnitions. 2014. www.u
org/Page/Name/grade-deﬁnitions.12
USPSTF, U.S. Preventive Services Task Force.these considerations help the Task Force determine
whether there is convincing evidence that is derived
from several high-quality studies with consistent, logical
results that are generalizable to the U.S. primary care
population and setting; adequate evidence, when most
but not all of the six considerations are answered
favorably; or inadequate evidence, in cases where the
evidence is lacking, conﬂicting, or the studies are of poor
quality individually or in aggregate.
With convincing or adequate evidence, the Task Force
can move forward in determining the levels of certainty
for net beneﬁt. High certainty requires convincing
evidence (consistent results from well-designed, well-
conducted studies in representative primary care pop-
ulations) of overall assessed effects of the preventive
service on both beneﬁcial and harmful health outcomes.
With high certainty, the USPSTF judges that, given the
size and quality of the evidence, conclusions are unlikely
to change with future studies. Moderate certainty indi-
cates a determination that the available evidence is
sufﬁcient to determine the effects of the preventive
service on health outcomes. There is some constraint
on conﬁdence in the evidence based on factors such as
the number, size, or quality of individual studies; incon-
sistency of ﬁndings across studies; limited generalizability
to routine primary care practice; or a lack of coherence in
the chain of evidence. Given these constraints, it is
possible for the conclusions to change with future
research.
Low certainty indicates either that the overall evidence
base is inadequate or that the available evidence is
insufﬁcient to assess overall effects on health outcomes
because of a limited number or size of studies, importantLetter Grade Deﬁnitions
ainty that the net beneﬁt is
ainty that the net beneﬁt is
eneﬁt is moderate to
g this service to individual
references. There is at
moderate or high certainty
utweigh the beneﬁts.
ufﬁcient to assess the
is lacking, of poor quality,
annot be determined.
spreventiveservicestaskforce.ﬂaws in study design or meth-
ods, inconsistency of ﬁndings
across individual studies, gaps
in the chain of evidence, ﬁnd-
ings that are not generalizable
to the primary care population,
or lack of information on
important health outcomes.
This conclusion could change
with more information from
future studies that mitigate
these limitations.Using the U.S. Preventive
Services Task Force
Recommendation Grid
The USPSTF’s overall judg-
ment of their certainty of net
beneﬁt based on results of thewww.ajpmonline.org
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in the analytic framework coalesces with the determi-
nation of a letter grade recommendation from the Task
Force. Figure 2 illustrates the recommendation grid used
by the Task Force to arrive at a letter grade. As discussed
above, the Task Force evaluates the evidence for beneﬁts
of a preventive service in terms of improved outcomes in
individuals without signs or symptoms of the target
condition (e.g., cardiovascular disease, cancer) along with
evidence for any harm associated with the preventive
service (e.g., overdiagnosis and over-treatment, stigma
associated with labeling, radiation exposures) and
assesses the level of net beneﬁt (beneﬁts minus harm).
Depending on the preventive service, it may be possible
to quantify net beneﬁt (e.g., lives saved by a preventive
service minus lives lost from negative effects of the
service). Other services (e.g., behavioral counseling
interventions) are rarely associated with serious morbid-
ity or mortality, and so the assessment is often less
quantitative. Assuming evidence for beneﬁts and reason-
able data or assumptions about harm, the Task Force
determines whether the net beneﬁt is substantial, mod-
erate, small, or of no beneﬁt/negative.
The letter grade is determined based on both the
magnitude of the net beneﬁt and the certainty with which
that determination was made. As shown in Figure 2, a
preventive service for which there is a substantial net
beneﬁt with high certainty receives a letter grade of A.
Recommendations with a B letter grade are for services
that demonstrate substantial beneﬁt with high certainty or
moderate beneﬁt with high or moderate certainty. Both A
and B letter grades indicate a recommendation for
primary care providers to routinely provide theFigure 2. U.S. Preventive Services Task Force recommendation
Source: U.S. Preventive Services Task Force. Procedure Manual, Table 3. 2
http://www.uspreventiveservicestaskforce.org/Page/Name/procedure-manu
September 2015preventive service. Preventive services with moderate to
high certainty of a small net beneﬁt are given a C letter
grade. These services are not routinely recommended, but
are recommended to be selectively provided based on
clinical judgment and patient preferences. Any preventive
service that evidences no net beneﬁt or a negative net
beneﬁt (i.e., harm outweighs beneﬁts) is given a D letter
grade, and the service is not recommended in primary
care practice. For preventive services with low certainty,
the available evidence is insufﬁcient for making a
recommendation and those services are given an I
letter grade.
The approach to evidence by the USPSTF has been
previously articulated,11,14,15 with speciﬁc consideration
of the challenges of behavioral counseling topics.16,17 As
detailed in the rest of this supplement, many challenges
remain and this supplement represents renewed efforts
to address them. To provide a brief example, we consider
a recently updated behavioral counseling recommenda-
tion, “Screening and Behavioral Counseling Interven-
tions in Primary Care to Reduce Alcohol Misuse: U.S.
Preventive Services Task Force Recommendation State-
ment.”18 In May 2013, the USPSTF published its ﬁnal
updated recommendation for screening, behavioral
counseling, and referral in primary care to reduce alcohol
misuse. The complete recommendation and evidence
report can be obtained at www.uspreventiveservicestask
force.org/uspstf/uspsdrin.htm.19 Figure 3 shows the ana-
lytic framework used by the Task Force and EPC that
included six key questions related to screening, inter-
vention, behavior change, long-term health outcomes,
and adverse effects or harm of either screening or
intervention. The framework also noted particular sub-grid.
013.13
al—table-3.groups of interest. Figure 4 shows the
disposition of articles reviewed for
inclusion in the evidence review. Ulti-
mately, the quantitative synthesis
included 19 of 29 studies identiﬁed
from a full-text review of 718/6,265
records identiﬁed in the scientiﬁc data-
base search. Figure 5 shows forest plots
for three different measures of alcohol
consumption from the included
studies.19
Overall, there was evidence that
interventions to reduce alcohol misuse
in screening-identiﬁed individuals
reduced the frequency of binge drink-
ing episodes, total number of drinks
per week, and prevalence of drinking
more than recommended limits. These
data conﬁrmed the ﬁndings of the
previous review.20 However, changes
Figure 3. U.S. Preventive Services Task Force analytic framework for screening, behavioral counseling, and referral in primary
care to reduce alcohol misuse.
Source: Jonas DE, Garbutt JC, Brown JM, et al. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse. Comparative
Effectiveness Review No. 64. AHRQ Publication No. 12-EHC055-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.19
Note: KQ 1–6 refer to key questions addressed by this framework.
Curry and Whitlock / Am J Prev Med 2015;49(3S2):S129–S137S134in drinking behavior are not inherently clear with respect
to health beneﬁts. Thus, the systematic review included
scientiﬁc literature linking increased alcohol consump-
tion levels to higher risk for traumatic injury or death,
which the Task Force accepted as adequate evidence of a
health beneﬁt.21,22 The Task Force concluded that the
harm associated with screening and intervention was no
greater than small. Thus, the ﬁnal evidence appraisal was
that there is a moderate net beneﬁt to alcohol misuse
screening and brief behavioral counseling interventions
in the primary care setting for adults aged 18 years or
older. Using the recommendation grid, the USPSTF
assigned a B grade to a recommendation that clinicians
screen adults aged 18 years or older for alcohol misuse
and provide individuals engaged in risky or hazardous
drinking with brief behavioral counseling interventions
to reduce alcohol misuse. This recommendation blends
evidence on the effect on alcohol use and the evidence for
a relationship between alcohol use and morbidity and
mortality from traumatic injury or death.
The Task Force concluded that the evidence on
alcohol misuse screening and brief behavioral counsel-
ing interventions in the primary care setting for adoles-
cents is insufﬁcient and so the balance of beneﬁts andharm cannot be determined. Using the recommendation
grid, the Task Force assigned an I statement to this
conclusion.
This topic also illustrates some of the current chal-
lenges in developing behavioral counseling recommen-
dations that were recently outlined.17 These challenges
include clearly deﬁning study populations, feasibility of
practice or referral for counseling, deﬁning the compo-
nents and intensity of interventions, assessing potential
adverse effects, deﬁning behavioral outcome measures,
and linking behavior change to health outcomes.
As noted above, the Task Force concluded that there is
insufﬁcient evidence regarding screening and interven-
tion for alcohol misuse among adolescents. Although
there is a robust literature related to adolescent and
young adult alcohol misuse interventions on college
campuses, the social setting and intervention opportu-
nities cannot be extrapolated to a primary care setting.
Second, it was not possible in this recommendation to
specify with certainty the required elements or level of
intensity of intervention for reproducing the trial effects
in community practice. When lacking a common
language for describing intervention components, it
can appear that different studies are testing uniquewww.ajpmonline.org
Figure 4. Disposition of articles.
Source: Jonas DE, Garbutt JC, Brown JM, et al. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse. Comparative
Effectiveness Review No. 64. AHRQ Publication No. 12-EHC055-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.19
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tions are usually applied to higher-risk individuals,
intervention intensity is often confounded by population
risk. Finally, intervention intensity is a multidimensional
construct that may be represented by total hours of
intervention, hours of interpersonal contact, number of
contacts, duration of time over which intervention
contacts occur, format of intervention, training and skills
level of interventionists, and other factors. These multiple
factors are rarely reported consistently and there is no
clear metric for combining them into a formula for
clinical settings. Thus, we are often left with “best
practice” examples of what works with little evidence-
based guidance for tailoring to speciﬁc healthcare
settings.
Third, behavioral outcomes are proxies for health
outcomes, but are difﬁcult to quantitatively relate to
these. Often the outcome measurement approach varies
and must be converted to standardized mean differences
or recalculated to represent the same approximate
construct. In the alcohol misuse example, conversions
to mean drinks per week could be done across many
studies, but these mean changes were not as clearlySeptember 2015meaningful in terms of health outcomes as, for example,
mean blood pressure changes would be. Two of three
outcomes for alcohol misuse could be calculated as
proportions, allowing risk difference summarization
and conversion to number needed to screen or treat.
The proportion beneﬁting is rarely reported in behavioral
counseling trials, but is extremely useful for decision
makers. In these examples, choices about which out-
comes should be primary and when to assume homoge-
neity sufﬁcient to combine studies meta-analytically are
hidden, critical methodologic issues that can be partic-
ularly challenging and prone to bias or error for these
types of topics.
Fourth, evidence for harm is generally less robust than
for beneﬁts across all types of clinical preventive services
and is infrequently reported for behavioral counseling.
Although the Task Force generally considers the poten-
tial adverse effects of behavioral counseling to be small,
there can be important effects that warrant assessment.
For example, potential adverse effects of addressing
alcohol misuse could include increased use of other
substances, stigma, labeling, discrimination, or interfer-
ence with the patient–provider relationships.17
Figure 5. Forest plots for alcohol consumption, heavy drinking, and achieving recommended drinking limits.
Source: Jonas DE, Garbutt JC, Brown JM, et al. Screening, Behavioral Counseling, and Referral in Primary Care to Reduce Alcohol Misuse. Comparative
Effectiveness Review No. 64. AHRQ Publication No. 12-EHC055-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2012.19
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counseling are still developing, systematic reviewers and
guideline developers like the USPSTF face ever-
increasing scrutiny, time, and resource pressures. Given
the complexity of the interventions, the intermediate
nature of most of the outcomes, and the importance of
being able to feasibly provide or refer patients to effective
interventions, behavioral counseling topics are challeng-
ing. The remainder of this supplement is devoted to the
exploration of collaborative perspectives among
researchers, research funders, and the USPSTF in order
to optimize the evidence base and reduce the barriers to
realizing the impact of evidence-based behavioral coun-
seling interventions in primary care settings.Publication of this article was supported by the Agency for
Healthcare Research and Quality (AHRQ).
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